EUVIMEDEUVIMED entdecken
Crossref

Concordance and Proportion of Equivocal Results of Silver-Enhanced <i>In Situ</i> Hybridization and Immunohistochemical Technique for the Determination of HER2 Amplification in Breast Cancer Patients

Soon Ha Kwon, Deuk Young Lee, Jong Eun Lee, Jihyoun Lee, Sun Wook Han, Sung Yong Kim, Moo Jun Baek, Hyun Ju Lee, Mee-Hye Oh

Journal of Breast Disease · 2014

DOI: 10.14449/jbd.2014.2.37 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Breast Disease, 2014. Verfasst von Soon Ha Kwon und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Information on the status of human epidermal growth factor receptor 2 (HER2) is important for treatment planning in breast cancer; therefore, equivocal results of HER2 overexpression obtained using immunohistochemical staining (IHC) require additional evaluation regarding HER2 amplification, which can be obtained by other techniques such as fluorescence in situ hybridization (FISH) assay.The silver-enhanced in situ hybridization (SISH) technique is known to be comparable with FISH and can be performed under a bright field microscope.In this study, the authors evaluated the concordance between the results obtained by IHC and SISH used for determining HER2 status.

Methods

Paraffin-embedded tissues from 511 breast cancer patients were prepared and the medical records of the patients were reviewed.HER2 amplification status was evaluated by SISH assay by determining the HER2/chromosome 17 ratio or HER2 copy number status.The slides were blindly reviewed without IHC information.

Results

Among the collected tissues, invasive ductal carcinoma was detected in 440 patients (86.1%) and 27 (5.3%)showed ductal carcinoma in situ.The concordance rate between the results obtained by IHC and SISH was 90.6% (κ= 0.723).Two cases of negative IHC results had equivocal SISH results.

Conclusion

SISH was found to be a useful method for evaluating HER2 status in case of an equivocal result of IHC.

Zitieren

APA

Kwon, S. H., Lee, D. Y., Lee, J. E., Lee, J., Han, S. W., Kim, S. Y., Baek, M. J., Lee, H. J., & Oh, M. (2014). Concordance and Proportion of Equivocal Results of Silver-Enhanced In Situ Hybridization and Immunohistochemical Technique for the Determination of HER2 Amplification in Breast Cancer Patients. Journal of Breast Disease. https://doi.org/10.14449/jbd.2014.2.37

Vancouver

Kwon SH, Lee DY, Lee JE, Lee J, Han SW, Kim SY, et al. Concordance and Proportion of Equivocal Results of Silver-Enhanced In Situ Hybridization and Immunohistochemical Technique for the Determination of HER2 Amplification in Breast Cancer Patients. Journal of Breast Disease. 2014. doi:10.14449/jbd.2014.2.37

BibTeX
@article{Kwon2014,
  author = {Kwon, Soon Ha and Lee, Deuk Young and Lee, Jong Eun and Lee, Jihyoun and Han, Sun Wook and Kim, Sung Yong and Baek, Moo Jun and Lee, Hyun Ju and Oh, Mee-Hye},
  title = {Concordance and Proportion of Equivocal Results of Silver-Enhanced In Situ Hybridization and Immunohistochemical Technique for the Determination of HER2 Amplification in Breast Cancer Patients},
  journal = {Journal of Breast Disease},
  year = {2014},
  doi = {10.14449/jbd.2014.2.37}
}
Kostenlos starten →